CEO Benny Sørensen, MD, PhD,

Hemab Therapeutics Raises $157 Million to Transform the Future of Rare Bleeding Disorder Care

For a biotech world often focused on oncology and gene editing, Hemab Therapeutics has carved out a very different frontier: rare, inherited bleeding disorders that have long gone overlooked. The company has raised $157 million in a Series C round, a multifold oversubscribed financing led by Sofinnova Partners, with participation from a global sovereign wealth…

Read More

Squirro Expands AI Capabilities with Acquisition of Synaptica

In a significant move to bolster its enterprise AI offerings, Squirro, a prominent Swiss SaaS platform, has acquired Synaptica, a leading US-based provider specializing in enterprise taxonomy management and knowledge graph systems. This strategic acquisition aims to integrate Synaptica’s advanced semantic graph technology with Squirro’s cutting-edge generative AI capabilities, paving the way for enhanced knowledge…

Read More

Jade Biosciences Secures $80 Million Funding to Advance Breakthrough Therapies for Autoimmune Diseases

Jade Biosciences, a biotechnology innovator focused on autoimmune diseases, has announced the successful closing of an $80 million financing round. Led by Fairmount and Venrock Healthcare Capital Partners, with additional contributions from Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, and Braidwell LP, this investment will drive the development of Jade’s cutting-edge therapies…

Read More

CesiumAstro Soars with $65M Funding to Pioneer Next-Gen Space Communications

CesiumAstro Inc., a trailblazer in space communications technology, has secured a significant milestone in its journey with the closing of a Series B+ funding round, amassing a formidable $65 million. Led by Trousdale Ventures and bolstered by strategic investments from Development Bank of Japan Inc. and Quanta Computer, Inc., among others, this funding round marks…

Read More

KOR Closes Series B Funding Round Led by Macquarie to Accelerate Global Derivatives Reporting Expansion

In the complex world of derivatives reporting, one fintech startup is accelerating its global ambitions with a fresh infusion of capital. KOR, a US-based innovator focused on trade and transaction reporting technology, has closed a significant Series B funding round led by Macquarie Capital Venture Capital, alongside continued backing from existing investor Mosaik Partners. This…

Read More

3M Invests in Ohmium to Boost Green Hydrogen Production Technology

3M has solidified its commitment to advancing climate technologies with a strategic investment in Ohmium International, a pioneer in proton exchange membrane (PEM) electrolyzer systems for green hydrogen production. This investment underscores 3M’s proactive stance in supporting sustainable solutions aimed at fostering a low-carbon economy. Mark Copman, Senior Vice President of 3M New Growth Ventures,…

Read More

Aikido Technologies Secures $4M Seed Funding to Revolutionize Floating Wind Innovation

Aikido Technologies, a pioneering force in the floating wind sector, has announced the successful closure of its oversubscribed $4 million Series Seed investment round. Led by Azolla Ventures and supported by Propeller Ventures, Sabanci Climate Ventures, Cisco Foundation, Anthropocene Ventures, and others, this funding marks a significant milestone for Aikido as it accelerates the development…

Read More

Formlabs Expands Horizons with Acquisition of Micronics, Pioneers of Accessible 3D Printing Technology

In a bold move that underscores its commitment to innovation in 3D printing, Formlabs has announced the acquisition of Micronics, a dynamic startup emerging from the heart of Wisconsin. Founded by Henry Chan and Luke Boppart, Micronics has distinguished itself with a groundbreaking approach to Selective Laser Sintering (SLS) technology, traditionally confined to high-cost industrial…

Read More

opus1.io Secures Strategic Investment from Five Elms Capital to Propel Growth and Innovation in Performing Arts Management

opus1.io, a leading provider of end-to-end practice management solutions for lesson and class-based performing arts businesses, announced a significant strategic investment from Five Elms Capital. This funding infusion underscores Five Elms Capital’s confidence in opus1.io’s transformative platform, designed to streamline operations and foster growth within the performing arts sector. Founded by Sam Lellouche, a seasoned…

Read More

NeOnc Technologies Secures $18.5 Million to Propel Breakthrough Brain Cancer Therapies Through Phase II Trials

NeOnc Technologies Holdings, Inc., a forefront player in clinical-stage biotechnology, has successfully concluded an $18.5 million financing round aimed at advancing its innovative approach to treating brain cancer. This funding milestone includes new equity investment and debt conversions, reflecting a substantial increase in NeOnc’s valuation and reinforcing its commitment to pioneering neurological therapeutics. The financing…

Read More